The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Updated results of neoadjuvant chemotherapy with carboplatin AUC 6 and docetaxel 75 mg/m2 in triple-negative breast cancer (TNBC).
Peter Kern
No relevant relationships to disclose
Hans C. Kolberg
No relevant relationships to disclose
Anne Kalisch
No relevant relationships to disclose
Rainer Kimmig
No relevant relationships to disclose
Dirk Pott
No relevant relationships to disclose
Friedrich Otterbach
No relevant relationships to disclose
Christian M. Kurbacher
No relevant relationships to disclose